Skip to main content
Signal8

CapForce Inc. (OPGN) Form 10-K — May 26, 2026

$OPGNForm 10-KFiled May 26, 2026, 4:44 PM ET0001829126-26-005672Original filing

CapForce Inc. (formerly OpGen Inc.) reported $30.2 million in revenue for the year ended December 31, 2025, a 481% increase year-over-year, driven primarily by $30.2 million in listing sponsorship services. The company generated $23.6 million in net income, marking a sharp turnaround from its previous biotech operations which were deconsolidated following insolvency proceedings of its former subsidiaries, Curetis and Ares Genetics. The company has fully repositioned itself as a financial services and technology firm, focusing on capital markets advisory and a digital investment banking platform.

Key figures

Revenue
30200000
Net Income
23600000
Total Debt
0
Revenue Yoy
481%
Cash Position
500000
Shares Outstanding
12178278
Operating expenses
6171922
Gross proceeds 2024
5000000
Gross proceeds 2025
500000
Reverse split ratio
1:10
Aei ownership percent
76.1
Product sales revenue
0
Laboratory services revenue
0
Listing sponsorship revenue
30200000

Price after filing

1 day: 0.0%

Close on the filing date to close N calendar days later (from $1.50). Historical, not a forecast.

AI analysis

Red flags7 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.